Cleared Traditional

K133098 - SENYINT PACS

K133098 is an FDA 510(k) clearance for SENYINT PACS, manufactured by Dalian Senyint Digital Medical System Co., Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 256-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
256d
Days
Class 2
Risk

K133098 is an FDA 510(k) clearance for the SENYINT PACS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Dalian Senyint Digital Medical System Co., Ltd. (Dover, US). The FDA issued a Cleared decision on June 13, 2014 after a review of 256 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Dalian Senyint Digital Medical System Co., Ltd. devices

FDA 510(k) Submission Details - K133098

510(k) Number K133098 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2013
Decision Date June 13, 2014
Days to Decision 256 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
149d slower than avg
Panel avg: 107d · This submission: 256d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1852
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K133098.
QUENTRY DOSE REVIEW
K141199 · Brainlab AG · Jun 2014
RADSPA
K141329 · Telerad Tech Private Limited · Jun 2014
PLANMECA ROMEXIS
K140713 · Planmeca Oy · Jun 2014
PICTURE ARCHIVING AND COMMUNICATIONS SYSTEM
K140960 · Hologic, Inc. · Jun 2014
MEDICAD CLASSIC
K140434 · Hectec GmbH · Jun 2014
BRIGHTMATTER PLANNING SOFTWARE
K140337 · Synaptive Medical, Inc. · Jun 2014